David Cohen, MD MSc
January 23rd, 2012
Drug-Eluting vs. Bare-Metal Stents, Using Instrumental Variable Analysis
David Cohen, MD MSc
David J. Cohen, the principal investigator of an observational PCI registry study of drug-eluting versus bare-metal stents, sheds light on a risk-adjustment technique called “instrumental variable analysis.” CardioExchange welcomes your thoughts on the value of this method and on the study it was used to elucidate. The Study Using data from a prospective observational PCI registry, researchers […]
March 16th, 2011
CABG vs. PCI for Angina Relief: Lessons from SYNTAX
David Cohen, MD MSc
CardioExchange welcomes David J. Cohen, Director of Cardiovascular Research at St. Luke’s Mid America Heart Institute in Kansas City, Missouri, to discuss the latest analysis from the SYNTAX randomized trial. The study has just been published in the New England Journal of Medicine, and Dr. Cohen is the lead author. Questions to Dr. Cohen come […]
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy